Search

Your search keyword '"Touré Kane, Coumba"' showing total 5 results
Start Over Author "Touré Kane, Coumba" Publication Year Range Last 3 years
5 results on '"Touré Kane, Coumba"'

2. Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial

Author

Anglaret, Xavier, Assoumou, Lambert, Bado, Guillaume, Bissagnene, Emmanuel, Bonnet, Fabrice, Britto, Carlos, Brun Vezinet, Françoise, Charpentier, Charlotte, Chazallon, Corine, Chenal, Henri, Chêne, Geneviève, Chenier, Remy, Clouet, Gwenaelle, Colin, Géraldine, Collin, Gilles, Conte, Valérie, Danel, Christine, De Monteynard, Laure-Amélie, Dembele, Fassery, Diallo, Zelica, Diallo, Illah, Dohoun, Lambert, Drabo, Youssouf Joseph, Eholié, Serge Paul, Ekouevi, Didier Koumavi, Fadiga, Fatoumata, Gabillard, Delphine, Girard, Pierre Marie, Gottlieb, Geoffrey S., Hawerlander, Denise, Karcher, Sophie, Kariyiare, Benjamin, Koita Fall, Mame Basty, Konan, Romuald, Kouame, Antoine, Kouley, Serge-Olivier, Laborde Bolen, Gabriele, Landman, Roland, Le Carrou, Jérome, Marcelain, Anne Geneviève, Matheron, Sophie, Mensah, Ephrem, Mercier, Noémie, Messou, Assoua, Messou, Eugène, Minga, Albert, N'dour, Cheick Tidiane, N'chot, Celestin, Ndiaye, Bara, Ngom Gueye, Ndeye Fatou, N'guessan-Koffi, Larissa, Ouattara, Eric, Ouédraogo, Abdoul-Salam, Palokinam Pitche, Vincent, Peytavin, Gilles, Plantier, Jean Christophe, Poda, Armel, Prince-David, Mireille, Raffali, Yasmine, Rekacewicz, Claire, Rouzioux, Christine, Salou, Mounerou, Sangare, Lassana, Sawadogo, Adrien Bruno, Seydi, Moussa, Somé, Désiré, Tamegnon, Séphora, Tchabert-Guié, Annick, Tchounga, Boris, Toni, Thomas d'Aquin, Toure Kane, Coumba, Touret, Pierre, Traoré, Jean-Richard, Vitoria de Avila, Marco Antonio, Yaméogo, Seydou, Yao Yapi, Cyrille, Zoungrana, Jacques, Eholie, Serge P, Ekouevi, Didier K, Toni, Thomas-d'Aquin, and Brun-Vezinet, Françoise

Published
2024
Full Text
View/download PDF

3. WED-178 - Long-term outcomes of a population-based cohort of chronic hepatitis B (CHB) patients in West Africa

Author

Ndow, Gibril, Shimakawa, Yusuke, Leith, Damien, Bah, Sulayman, Bangura, Rohey, Bojang, Lamin, Ceesay, Amie, Bola-Lawal, Queen, Touray, Alhagie, Jatta, Abdoulie, Barry, Jainaba, Nyassi, Fatou Bintou, Lambert, Gabriel, Cook, Amelia, Ingiliz, Patrick, Bittaye, Sheikh Omar, Haddadin, Yazan, Quang, Erwan Vo, Chevaliez, Stéphane, Cloherty, Gavin, Lo, Gora, Toure-Kane, Coumba, Chemin, Isabelle, Njie, Ramou, Umberto, Dalessandro, Thursz, Mark, and Lemoine, Maud

Published
2023
Full Text
View/download PDF

4. OS-090-YI - Estimating the residual risk of hepatitis B mother-to-child transmission in The Gambia, 30 years after HBV vaccine implementation

Author

Ndow, Gibril, Bangura, Rohey, Quang, Erwan Vo, Touray, Fatoumatta, Jatta, Abdoulie, Barry, Jainaba, Bah, Sulayman, Nyassi, Fatou Bintou, Bola-Lawal, Queen, Touray, Alhagie, Drammeh, Sainabou, Cham, Hawa, Cloherty, Gavin, Lo, Gora, Toure-Kane, Coumba, Bojang, Lamin, Shimakawa, Yusuke, D’Alessandro, Umberto, and Lemoine, Maud

Published
2023
Full Text
View/download PDF

5. Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).

Author

Périères, Lauren, Diallo, Aldiouma, Marcellin, Fabienne, Nishimwe, Marie Libérée, Ba, El Hadji, Coste, Marion, Lo, Gora, Halfon, Philippe, Touré Kane, Coumba, Maradan, Gwenaëlle, Carrieri, Patrizia, Diouf, Assane, Shimakawa, Yusuke, Sokhna, Cheikh, Boyer, Sylvie, Bérenger, Cyril, Bousmah, Marwan al Qays, de Seze, Maëlle, Djaogol, Tchadine, and Treibich, Carole

Subjects
HEPATITIS B, HEPATITIS associated antigen, YOUNG adults, AGE groups, DISEASE prevalence
Abstract

Senegal introduced the infant hepatitis B virus (HBV) vaccination in 2004 and recently committed to eliminating hepatitis B by 2030. Updated epidemiological data are needed to provide information on the progress being made and to develop new interventions. We estimated the prevalence of hepatitis B surface antigen (HBsAg) in children and adults living in rural Senegal and assessed hepatitis B treatment eligibility. A cross‐sectional population‐based serosurvey of HBsAg was conducted in 2018‐2019 in a large sample (n = 3,118) of residents living in the Niakhar area (Fatick region, Senegal). Individuals positive for HBsAg subsequently underwent clinical and biological assessments. Data were weighted for age and sex and calibrated to be representative of the area's population. Among the 3,118 participants, 206 were HBsAg positive (prevalence, 6.9%; 95% confidence interval [CI], 5.6‐8.1). Prevalence varied markedly according to age group in individuals aged 0‐4, 5‐14, 15‐34, and ≥35 years as follows: 0.0% (95% CI, 0.00‐0.01); 1.5% (95% CI, 0.0‐2.3); 12.4% (95% CI, 9.1‐15.6); and 8.8% (95% CI, 6.1‐11.5), respectively. Of those subsequently assessed, 50.9% (95% CI, 41.8‐60.0) had active HBV infection; 4 (2.9%; 95% CI, 0.9‐9.4) were eligible for hepatitis B treatment. Conclusion: In this first population‐based serosurvey targeting children and adults in rural Senegal, HBsAg prevalence was very low in the former, meeting the World Health Organization's (WHO) < 1% HBsAg 2020 target; however, it was high in young adults (15‐34 years old) born before the HBV vaccine was introduced in 2004. To reach national and WHO hepatitis elimination goals, general population testing (particularly for adolescents and young adults), care, and treatment scale‐up need to be implemented. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results